Stanley-Laman Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Sell |
8,302
-653
| -7% | -$254K | 0.48% | 95 |
|
|
2025
Q1 | $3.9M | Buy |
8,955
+747
| +9% | +$325K | 0.6% | 67 |
|
|
2024
Q4 | $3.03M | Buy |
8,208
+648
| +9% | +$239K | 0.43% | 105 |
|
|
2024
Q3 | $3.93M | Sell |
7,560
-266
| -3% | -$138K | 0.55% | 80 |
|
|
2024
Q2 | $4.24M | Buy |
7,826
+357
| +5% | +$193K | 0.61% | 65 |
|
|
2024
Q1 | $3.87M | Sell |
7,469
-39
| -0.5% | -$20.2K | 0.54% | 84 |
|
|
2023
Q4 | $3.54M | Sell |
7,508
-107
| -1% | -$50.5K | 0.54% | 75 |
|
|
2023
Q3 | $3.32M | Sell |
7,615
-194
| -2% | -$84.5K | 0.57% | 72 |
|
|
2023
Q2 | $3.47M | Buy |
7,809
+648
| +9% | +$288K | 0.57% | 74 |
|
|
2023
Q1 | $3.29M | Buy |
7,161
+6,495
| +975% | +$2.99M | 0.59% | 74 |
|
|
2022
Q4 | $342K | Sell |
666
-466
| -41% | -$239K | 0.07% | 177 |
|
|
2022
Q3 | $514K | Hold |
1,132
| – | – | 0.1% | 170 |
|
|
2022
Q2 | $546K | Sell |
1,132
-229
| -17% | -$110K | 0.1% | 190 |
|
|
2022
Q1 | $669K | Buy |
1,361
+679
| +100% | +$334K | 0.09% | 195 |
|
|
2021
Q4 | $316K | Hold |
682
| – | – | 0.04% | 233 |
|
|
2021
Q3 | $254K | Hold |
682
| – | – | 0.03% | 244 |
|
|
2021
Q2 | $260K | Hold |
682
| – | – | 0.04% | 236 |
|
|
2021
Q1 | $245K | Hold |
682
| – | – | 0.04% | 231 |
|
|
2020
Q4 | $219K | Buy |
+682
| New | +$219K | 0.04% | 227 |
|
|
2020
Q1 | – | Sell |
-666
| Closed | -$201K | – | 266 |
|
|
2019
Q4 | $201K | Buy |
+666
| New | +$201K | 0.05% | 262 |
|
|
2017
Q4 | – | Sell |
-3,726
| Closed | -$707K | – | 278 |
|
|
2017
Q3 | $707K | Buy |
3,726
+470
| +14% | +$89.2K | 0.19% | 131 |
|
|
2017
Q2 | $613K | Buy |
3,256
+25
| +0.8% | +$4.71K | 0.17% | 131 |
|
|
2017
Q1 | $534K | Sell |
3,231
-19,148
| -86% | -$3.16M | 0.14% | 159 |
|
|
2016
Q4 | $3.22M | Buy |
22,379
+11,251
| +101% | +$1.62M | 1% | 10 |
|
|
2016
Q3 | $1.39M | Buy |
11,128
+1,607
| +17% | +$201K | 0.57% | 39 |
|
|
2016
Q2 | $1.25M | Buy |
+9,521
| New | +$1.25M | 0.49% | 52 |
|